COSCIENS Biopharma Inc. (CSCIF) Revenue 2016–2025
COSCIENS Biopharma Inc. (CSCIF) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$7.5MFY2025 · since FY2016: $911,000 → $7.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $7.5M | -21.8% |
| FY2024 | $9.6M | +34.2% |
| FY2023 | $7.1M | -51.0% |
| FY2022 | $14.6M | +177.0% |
| FY2021 | $5.3M | +44.0% |
| FY2020 | $3.7M | +586.5% |
| FY2019 | $532,000 | -98.0% |
| FY2018 | $26.9M | +2812.4% |
| FY2017 | $923,000 | +1.3% |
| FY2016 | $911,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice